Takeda Pharmaceutical Company Limited - Company & Market Research Reports

Home /
Companies /
Takeda Pharmaceutical Company Limited

Takeda Pharmaceuticals is the largest pharmaceutical company in Asia and a top 15 pharmaceutical company in the world. It provides products in various therapeutic areas, including gastroenterology, oncology, central nervous system, cardiovascular and metabolic, vaccines, and others. Takeda was founded in 1781 and operates two primary bases in Japan in Osaka and Tokyo. Its global operations are based in Zurich, Switzerland.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 191
Endocrine and Metabolic Disorders Drugs 162
Gastrointestinal Drugs 147
Immune Disorders Drugs 129
Central Nervous System Drugs 127
Biopharmaceuticals 87
Pharmaceuticals 82
Hematological Drugs 78
Vaccines 78
Clinical Trials 70
Drug Discovery 64
Cardiovascular Drugs 60
Diabetes Drugs 56
Infectious Diseases Drugs 56
Leukemia Drugs 52
Mental Disorders Drugs 46
Lymphoma Drugs 42
Musculoskeletal Disorders Drugs 41
Infusions and Injectables 33
Liver and Kidney Disorders Drugs 32
Over the Counter (OTC) Drugs 30
Lung Cancer Drugs 23
Pharmaceutical Manufacturing 20
Sexual and Reproductive Health Drugs 20
Drug Delivery 19
Respiratory Drugs 19
Antibiotics 16
Analgesics 15
Drugs by Therapeutic Area 13
Immunosuppressive Drugs 13
Pharmaceutical Intermediates 12
Schizophrenia Drugs 12
Prostate Cancer Drugs 11
Skin Cancer Drugs 11
Optical Disorders Drugs 10
Anti-Obesity Drugs 9
Alzheimer's Disease Drugs 9
Generic Drugs 7
Biosimilars and Biosuperiors 7
Psoriasis Drugs 7
Addiction Disorders Drugs 6
Animal Pharmaceuticals 6
Colon Cancer Drugs 6
Thyroid Cancer Drugs 6
Dermatological Drugs 6
Urological Disorders Drugs 6
Transdermal and Transmucosal Drug Delivery 5
Uterine Cancer Drugs 5
Liver Cancer Drugs 4
Cervical Cancer Drugs 4
Brain Cancer Drugs 4
Company Reports 3
Breast Cancer Drugs 3
Kidney Cancer Drugs 3
HIV/AIDS Drugs 3
Ovarian Cancer Drugs 2
Cough and Cold Drugs 2
Anesthetic Drugs 2
Cancer Vaccines 2
Pancreatic Cancer Drugs 2
Vitamins and Dietary Supplements 2
Pharmacoeconomics 1
Inhalers and Nebulisers 1
Anxiety Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

1,646 Results (Page 32 of 83)
- Relevance
  Sort by

20s Proteasome Inhibitor - Pipeline Insight, 2025

 Clinical Trials
April 2025
90 Pages
Global

From

€1314EUR$1,500USD£1,134GBP

CCR2 Inhibitor - Pipeline Insight, 2025

 Clinical Trials
April 2025
90 Pages
Global

From

€1314EUR$1,500USD£1,134GBP

Aurora Kinase Inhibitor - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1314EUR$1,500USD£1,134GBP

Vestibular Schwannoma - Pipeline Insight, 2025

 Clinical Trials
April 2025
50 Pages
Global

From

€1314EUR$1,500USD£1,134GBP

Crohn Disease Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
August 2024
81 Pages
Global

From

€3500EUR$4,279USD£3,126GBP

NEED HELP FINDING THE RIGHT PRODUCT? Francesca will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1095EUR$1,250USD£945GBP

Denmark Pharmaceutical Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

 Report
April 2023
80 Pages
Denmark

From

€4162EUR$4,750USD£3,591GBP

Endometrial Cancer Treatment Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3934EUR$4,490USD£3,395GBP

Antibody Discovery Market Industry Trends and Global Forecasts to 2035: Distribution by Antibody Discovery Step, Antibody Discovery Method, Nature of, Type of Antibody, Therapeutic Area, End-user and Geographical Regions

 Report
June 2025
607 Pages
Global

From

€4204EUR$4,799USD£3,628GBP

Atypical Teratoid Rhabdoid Tumors (ATRT)- Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1095EUR$1,250USD£945GBP

Primary Hyperoxaluria Treatment Market Report and Forecast 2023-2031

 Report
April 2023
147 Pages
Global

From

€4336EUR$4,949USD£3,742GBP

Non-Alcoholic Steatohepatitis (NASH) Treatment Market Report and Forecast 2023-2031

 Report
March 2023
147 Pages
Global

From

€4336EUR$4,949USD£3,742GBP

Melanin Concentrating Hormone Receptor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
October 2024
74 Pages
Global

From

€3500EUR$4,279USD£3,126GBP

Colorectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
1588 Pages
Global

From

€2190EUR$2,500USD£1,890GBP

Cervical Cancer Therapeutics Market - Epidemiology & Pipeline Analysis 2022-2027

 Report
June 2022
191 Pages
Global

From

€3066EUR$3,500USD£2,646GBP

Antidiabetic SGLT-2 Inhibitor Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
September 2024
96 Pages
Global

From

€3500EUR$4,279USD£3,126GBP

Autoimmune Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
141 Pages
Global

From

€3500EUR$4,279USD£3,126GBP

Advanced Endometrial Cancer - Pipeline Insight, 2025

 Drug Pipelines
April 2025
60 Pages
Global

From

€1752EUR$2,000USD£1,512GBP

Antidiabetic Biguanides Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
September 2024
98 Pages
Global

From

€3500EUR$4,279USD£3,126GBP

Immunology Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type

 Report
February 2024
100 Pages
Global

From

€3500EUR$4,279USD£3,126GBP

1,646 Results (Page 32 of 83)
- 1
- 30
- 31
- 32
- 33
- 34

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.